Treatment With LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer

Human Gene Therapy - United States
doi 10.1089/hum.2008.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Antimicrobial Peptide LL-37 Is Bactericidal Against Staphylococcus Aureus Biofilms

PLoS ONE
Multidisciplinary
2019English

Interaction of Antimicrobial Peptide Ll-37 With Lipopolysaccharides

Biophysical Journal
Biophysics
2019English

Oxidative Stress Induced in E. Coli by the Human Antimicrobial Peptide LL-37

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2017English

Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats

Anesthesiology
AnesthesiologyPain Medicine
2007English

Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus Aureus-Derived Proteinases

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

The Antimicrobial Peptide, LL-37, Inhibits in Vitro Osteoclastogenesis

Journal of Dental Research
Dentistry
2012English

Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer

Cancer Research
Cancer ResearchOncology
2012English

CpG Oligodeoxynucleotides Stimulate Protective Innate Immunity Against Pulmonary Klebsiella Infection

Journal of Immunology
AllergyImmunology
2004English

The Pro-Inflammatory Peptide LL-37 Promotes Ovarian Tumor Progression Through Recruitment of Multipotent Mesenchymal Stromal Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy